title: Erlotinib-associated dermatological toxicity.
authors.affiliation: Department of Internal Medicine, Ospedale Civile Livorno, Livorno, Italy. nimumoli@tiscali.it
authors.forename: Nicola
authors.initials: N
authors.lastname: Mumoli
authors.forename: Marco
authors.initials: M
authors.lastname: Cei
authors.forename: Josè
authors.initials: J
authors.lastname: Vitale
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors